Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CP-320626

🥰Excellent
Catalog No. T31048Cas No. 186430-23-9
Alias CP320626

CP-320626 is a highly efficient human liver glycogen phosphorylase (GP) inhibitor with cholesterol-lowering activity. It inhibits cholesterol biosynthesis by directly inhibiting CYP51 and can be used in type 2 diabetes research.

CP-320626

CP-320626

🥰Excellent
Purity: 98.06%
Catalog No. T31048Alias CP320626Cas No. 186430-23-9
CP-320626 is a highly efficient human liver glycogen phosphorylase (GP) inhibitor with cholesterol-lowering activity. It inhibits cholesterol biosynthesis by directly inhibiting CYP51 and can be used in type 2 diabetes research.
Pack SizePriceAvailabilityQuantity
1 mg$293In Stock
5 mg$722In Stock
10 mg$987In Stock
25 mg$1,520In Stock
50 mg$1,980In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:98.06%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
CP-320626 is a highly efficient human liver glycogen phosphorylase (GP) inhibitor with cholesterol-lowering activity. It inhibits cholesterol biosynthesis by directly inhibiting CYP51 and can be used in type 2 diabetes research.
Targets&IC50
GP:205 nM
In vitro
Treatment of MIA PaCa-2 cancer cells with CP-320626 (25, 50 and 100 μM) showed significant changes in the dynamic expression of total protein and phosphoprotein. CP-320626 inhibits cholesterol production by directly inhibiting CYP51. [1]
CP-320626 (50-100 μM) regulates glucose homeostasis by inhibiting glycogen phosphorylase (GP) and thereby affecting glucose production. [3]
In vivo
In ob/ob mice, acute treatment with CP-320626 resulted in reduced liver cholesterol production, accompanied by lanosterol accumulation, further suggesting that CYP51 inhibition is the mechanism of cholesterol reduction in these animals. [2]
AliasCP320626
Chemical Properties
Molecular Weight443.9
FormulaC23H23ClFN3O3
Cas No.186430-23-9
SmilesC(N[C@H](C(=O)N1CCC(O)CC1)CC2=CC=C(F)C=C2)(=O)C=3NC=4C(C3)=CC(Cl)=CC4
Relative Density.1.401 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CP-320626 | purchase CP-320626 | CP-320626 cost | order CP-320626 | CP-320626 chemical structure | CP-320626 in vivo | CP-320626 in vitro | CP-320626 formula | CP-320626 molecular weight